We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-4.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$98.8B
AUM Growth
-$3.4B
Cap. Flow
+$2.69B
Cap. Flow %
2.72%
Top 10 Hldgs %
24.29%
Holding
4,219
New
200
Increased
1,781
Reduced
1,776
Closed
283
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MJ icon
2726
Amplify Alternative Harvest ETF
MJ
$112M
$612K ﹤0.01%
11,105
-1,941
-15% -$135K
WNS
2727
DELISTED
WNS Holdings
WNS
$612K ﹤0.01%
7,475
+1,649
+28% +$137K
CSWC icon
2728
Capital Southwest
CSWC
$1.61B
$609K ﹤0.01%
35,955
-714
-2% -$13.8K
POWR
2729
iShares U.S. Power Infrastructure ETF
POWR
$464M
$609K ﹤0.01%
28,528
-3,492
-11% -$77.5K
RFDA icon
2730
ALPS Dynamic US Dividend Advantage ETF
RFDA
$90.6M
$609K ﹤0.01%
15,629
+3,884
+33% +$172K
GUT
2731
Gabelli Utility Trust
GUT
$583M
$608K ﹤0.01%
90,428
-2,841
-3% -$20.9K
HP icon
2732
Helmerich & Payne
HP
$4.29B
$606K ﹤0.01%
16,399
-8,397
-34% -$353K
FATE icon
2733
Fate Therapeutics
FATE
$294M
$605K ﹤0.01%
26,984
-2,831
-9% -$81.8K
IGF icon
2734
iShares Global Infrastructure ETF
IGF
$10.7B
$604K ﹤0.01%
14,435
-7,948
-36% -$375K
CPE
2735
DELISTED
Callon Petroleum Company
CPE
$604K ﹤0.01%
17,250
-1,604
-9% -$64.1K
CUTR
2736
DELISTED
Cutera, Inc.
CUTR
$603K ﹤0.01%
13,224
+5,056
+62% +$231K
MEAR icon
2737
BlackRock Short Maturity Municipal Bond ETF
MEAR
$1.37B
$602K ﹤0.01%
12,126
+5,426
+81% +$270K
VIVO
2738
DELISTED
Meridian Bioscience Inc
VIVO
$599K ﹤0.01%
19,008
+6,414
+51% +$208K
NS
2739
DELISTED
NuStar Energy L.P.
NS
$596K ﹤0.01%
44,152
-3,048
-6% -$45.8K
FRSH icon
2740
Freshworks
FRSH
$3.51B
$595K ﹤0.01%
+45,899
New +$649K
NRP icon
2741
Natural Resource Partners
NRP
$1.36B
$595K ﹤0.01%
13,442
-1,577
-11% -$67.3K
BANX
2742
ArrowMark Financial
BANX
$200M
$594K ﹤0.01%
34,403
+6,437
+23% +$119K
RPT
2743
Rithm Property Trust
RPT
$99.9M
$594K ﹤0.01%
13,178
+7,866
+148% +$454K
EQAL icon
2744
Invesco Russell 1000 Equal Weight ETF
EQAL
$849M
$593K ﹤0.01%
16,041
+425
+3% +$17.5K
CPZ
2745
Calamos Long/Short Equity & Dynamic Income Trust
CPZ
$269M
$592K ﹤0.01%
39,616
+5,178
+15% +$88.3K
ARI
2746
Apollo Commercial Real Estate
ARI
$885M
$591K ﹤0.01%
71,148
+58,421
+459% +$670K
CZA icon
2747
Invesco Zacks Mid-Cap ETF
CZA
$193M
$591K ﹤0.01%
7,386
+516
+8% +$45.3K
JAMF
2748
DELISTED
Jamf
JAMF
$591K ﹤0.01%
26,666
+199
+0.8% +$4.92K
WU icon
2749
Western Union
WU
$2.34B
$591K ﹤0.01%
43,754
-17,985
-29% -$282K
RNST icon
2750
Renasant Corp
RNST
$4B
$590K ﹤0.01%
18,859
+17
+0.1% +$553

Similar funds

Raymond James & Associates's Q3 2022 Portfolio in Review

As of Q3 2022, Raymond James & Associates held 4,219 positions worth $98.8B, down 3.3% from $102B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q3 2022 filing shows 200 new, 1,781 increased, 1,776 reduced and 283 closed positions. Its largest new stake was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M. The largest sale was iShares Core 1-5 Year USD Bond ETF, an estimated $255M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q3 2022 buy was JPMorgan Nasdaq Equity Premium Income ETF: 332,653 shares worth $13.9M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q3 2022, an estimated $620M increase.
  • Raymond James & Associates's biggest Q3 2022 reduction was iShares Core 1-5 Year USD Bond ETF, cutting an estimated $255M.
  • Raymond James & Associates fully exited CDK Global, Inc. in Q3 2022, selling an estimated $36M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $98.8B portfolio in Q3 2022.
  • Raymond James & Associates opened 200 new positions and closed 283 in Q3 2022.
  • Raymond James & Associates's portfolio value fell 3.3% quarter-over-quarter to $98.8B.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.